AstraZeneca's Obesity Pills Revealed Positive Result In Phase I Trials
In its presentation at ObesityWeek 2024 meeting in Texas, the multinational drug company AstraZeneca (NASDAQ:AZN) revealed ...
Compass Pathways: Phase 3 Trial Delay - Both Understandable And Disappointing
Compass Pathways' latest update reveals extended trial timelines, staff cuts, and financial concerns, raising questions about ...
Bright Minds Biosciences: BMB-101's Phase 2 Trials Could Unlock Epilepsy Market Potential
Bright Minds Biosciences' BMB-101 shows promise in treating drug-resistant epilepsy. Read why DRUG stock is a strong ...
manilatimes5d
The Phase III clinical trial application for first-line treatment of extensive disease small cell lung cancer with Chiauranib has been approved
On November 1, Shenzhen Chipscreen Biosciences Co., Ltd. (hereinafter referred to as 'Chipscreen Biosciences') and its wholly-owned subsidiary Chengdu Chipscreen Pharmaceutical Ltd., received the ...
Three Phase 3 Trials of Datopotamab Deruxtecan-Based Combinations Initiated in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer
The first patients have been dosed in three global, randomized phase 3 trials evaluating the efficacy and safety of ...
Recce Phase II clinical trial reaches key dosing milestone
A Phase II clinical trial of RECCE 327 Topical Gel is nearing completion with data so far showing a strong therapeutic response.
stockhead on MSN5d
ASX Quarterly Health Wrap: Action for Dimerix Phase 3 kidney trial
PAR made substantial progress in its Phase 3 clinical trial preparations for the treatment of knee osteoarthritis (OA) with ...
Targeted Oncology1d
First Patients Dosed in New Phase 3 Trials of Dato-DXd in NSCLC
Three phase 3 trials of combinations including datopotamab deruxtecan for the treatment of non–small cell lung cancer are beginning.
Cure Today7d
First Patients Dosed in Phase 2 Trial of Ropidoxuridine for Glioblastoma
The initial trio of patients with glioblastoma have begun treatment with ropidoxuridine in a phase 2 clinical trial, ...
Multiple Sclerosis News Today2d
Dosing begins in early clinical trial of Lucid-MS to protect myelin sheath
A first healthy adults group has been dosed in an early clinical trial of an oral and myelin-protective treatment for all types of MS.
GemVax Announces Topline Results from Phase 2a Progressive Supranuclear Palsy Clinical Trial at Neuro2024
Topline supports moving to Phase 3 trial and shows potential to develop GV1001 as the world's first PSP treatment ...